SGA
REGN icon

Sector Gamma AS’s Regeneron Pharmaceuticals REGN Stock Holding History

Sector Gamma AS’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,165
Closed -$5.53M – 46
2025
Q4 		$5.53M Buy
+7,165
New +$4.87M 1.26% 26
2021
Q3 		– Sell
-4,876
Closed -$2.72M – 38
2021
Q2 		$2.72M Hold
4,876
– – 0.48% 36
2021
Q1 		$2.31M Buy
+4,876
New +$2.37M 0.42% 32
2020
Q1 		– Sell
-28,458
Closed -$10.7M – 35
2019
Q4 		$10.7M Sell
28,458
-47,377
-62% -$15.9M 1.71% 23
2019
Q3 		$21M Buy
75,835
+18,200
+32% +$5.39M 3.55% 9
2019
Q2 		$18M Buy
+57,635
New +$19.2M 2.9% 13
2018
Q3 		– Sell
-28,500
Closed -$9.83M – 35
2018
Q2 		$9.83M Buy
+28,500
New +$8.91M 1.63% 19

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Sector Gamma AS's REGN Position: Q1 2026 in Review

Sector Gamma AS sold out of Regeneron Pharmaceuticals (REGN) in Q1 2026, closing a stake of 7,165 shares — an estimated $5.53M sold.

Sector Gamma AS first reported a position in REGN in Q2 2018 and held it in 7 quarters. The position peaked at $21M in Q3 2019. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Sector Gamma AS reported no remaining Regeneron Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Sector Gamma AS sold 7,165 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $5.53M.
  • Sector Gamma AS first reported a position in Regeneron Pharmaceuticals in Q2 2018 and held it in 7 quarters.
  • Sector Gamma AS's Regeneron Pharmaceuticals position peaked at $21M in Q3 2019.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.